课题基金 / 基金详情

项目摘要

项目成果

KARL D. KIEBURTZ的其他基金

相似基金

相关文献

中文摘要
翻译
罗切斯特临床和转化科学奖(RCTSA)计划建议继续其双重 目标:1)组织,支持和扩大罗切斯特大学的临床和转化研究 在一个学术之家,罗切斯特大学临床和转化科学研究所(URCTSI), (2)与区域和国家机构进行整合和合作, 临床和转化研究网络。RCTSA计划真正改变了大学, 罗切斯特医疗中心(URMC),拥有最先进的临床和翻译中心, 科学大楼,将临床和转化科学融入URMC的共同愿景 研究,一个成功的动态治理系统,扩大研究资源, 参与并领导国家CTSA联盟。为了保持这一势头,UR-CTSI 将实现若干具体目标。首先,将实施三个新的关键功能: 合作伙伴关系,T1翻译和比较有效性研究。现有的主要职能将是 重组和合并,以便通过扩大的监管办公室为调查人员提供更好的支持 支持,导航/咨询服务,和孵化器计划巩固试点研究,小说 方法和翻译技术的关键功能。CTSI将建立和培育四个 跨研究翻译领域的卓越研究中心:人类实验中心 治疗学(T1研究);临床研究中心(T1-3研究);研究实施中心 和翻译(T2-3研究下的护理赞助学校);和中心的社区 健康(T2-3研究)。广泛的教育、培训和职业发展计划将继续下去 以满足研究人员的需求。UR-CTSI将积极参与国家CTSA 联合体,分享专门知识、方法、数据和课程。上州纽约翻译公司 将扩大研究网络,以支持该区域的生物医学研究机构。 最后,将通过衡量严格的业绩成果来评价UR-CTSI。
英文摘要
The Rochester Clinical and Translational Science Award (RCTSA) Program proposes continuation of its dual goals: 1) To organize, support, and expand clinical and translational research at the University of Rochester within an academic home, the University of Rochester Clinical and Translational Science Institute (URCTSI), and 2) To integrate and collaborate with regional and national institutions to expand a National Clinical and Translational Research Network. The RCTSA Program has truly transformed the University of Rochester Medical Center (URMC), with the construction of a state-of-the-art Clinical and Translational Science Building, the integration of clinical and translational science into the shared vision for URMC research, a successful system of dynamic governance, expansion of research resources, and enthusiastic participation and leadership in the National CTSA Consortium. To continue this momentum, the UR-CTSI will carry out a number of specific aims. First, three new key functions will be implemented: Public-Private Partnerships, T1 Translation, and Comparative Effectiveness Research. Existing Key Functions will be reorganized and consolidated to provide better support of investigators by an expanded Office of Regulatory Support, a Navigator/Consultation Service, and an Incubator Program consolidating Pilot Studies, Novel Methodologies, and Translational Technologies Key Functions. The CTSI will establish and foster four centers of research excellence across the spectrum of research translation: Center for Human Experimental Therapeutics (T1 Research); Clinical Research Center (T1-3 Research); Center for Research Implementation and Translation (T2-3 research under School of Nursing sponsorship); and Center for Community Health (T2-3 research). A broad range of education, training, and career development programs will continue to meet research workforce needs. The UR-CTSI will be an active participant in the National CTSA consortium with sharing of expertise, methods, data, and curricula. The Upstate New York Translational Research Network (UNYTRN) will be expanded to support the region's biomedical research institutions. Finally, the UR-CTSI will be evaluated through the measurement of rigorous performance outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Research Project 1 will develop in silico models that predict PD progression and inform clinical trial design
  • 批准号:
    10017340
  • 项目类别:
  • 资助金额:
    $17.21万
  • 财政年份:
    2018
  • 负责人:
    KARL D. KIEBURTZ
  • 依托单位:
Research Project 1 will develop in silico models that predict PD progression and inform clinical trial design
  • 批准号:
    10459490
  • 项目类别:
  • 资助金额:
    $17.73万
  • 财政年份:
    2018
  • 负责人:
    KARL D. KIEBURTZ
  • 依托单位:
Research Project 1 will develop in silico models that predict PD progression and inform clinical trial design
  • 批准号:
    10242056
  • 项目类别:
  • 资助金额:
    $17.73万
  • 财政年份:
    2018
  • 负责人:
    KARL D. KIEBURTZ
  • 依托单位:
U.S. India Collaborative Partnership in Parkinson Disease (CPPD)
  • 批准号:
    8337850
  • 项目类别:
  • 资助金额:
    $18.64万
  • 财政年份:
    2011
  • 负责人:
    KARL D. KIEBURTZ
  • 依托单位:
海外基金